Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
NCT01189864 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3493
Last updated 2018-10-12
Summary
The purpose of this study is to evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) as a method to increase the biomechanical and biochemical stability of the cornea by inducing additional cross-links within or between collagen fibers using UVA light and the photo- mediator riboflavin. The purpose of this study is to generate data for presentation at medical meetings and for peer-review publication. The data generated by this study will not be submitted to the FDA to support commercialization of these riboflavin drops.
Conditions
- Keratoconus
- Ectasia
- Degeneration
Interventions
- DRUG
-
Ciprofloxicin or Vigamox or other.
Ciprofloxicin or Vigamox or other to be used qid till epithelialized.
- DRUG
-
Nonsteroidal (Acular, Acuvail, Voltaren Xibrom, etc)
Nonsteroidal (Acular, Voltaren Xibrom, etc) qid up to 5-10 days post-op
- DRUG
-
Steroid (FML, Pred Forte, Flarex, etc.)
Steroid (FML, Pred Forte, Flarex, etc.) to be used qid to qd for 1-8 weeks.
Sponsors & Collaborators
-
Cxlusa
lead INDUSTRY
Principal Investigators
-
William Trattler, MD · The Center for Excellence in Eye Care
-
Jodi Luchs, MD · South Shore Eye Care LLP
-
Shamik Bafna, MD · Cleveland Eye Clinic
-
Parag Majmudar, MD · Chicago Cornea Consultants, LTD
-
Jay Schwartz, MD · Schwartz Laser Eye Center
-
Jonathan Davidorf, MD · Davidorf Eye Group
-
Daniel Goodman, MD · Goodman Eye Center
-
Jonathan Talamo, MD · Talamo Laser Eye Center
-
Sandy Feldman, MD · Clear View Eye & Laser Medical Center
-
Gregg Berdy, MD · Ophthalomology Associates
-
Lance Forstot · Corneal Consultants of Colorado, P.C
-
Mark Kontos, MD · Empire Eye Physicians
-
Audrey Rostov, MD · Northwest Eye Surgeons
-
John Hovanesian, MD · Harvard Eye Associates
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-02-01
- Primary Completion
- 2017-02-03
- Completion
- 2017-02-03
Countries
- United States
Study Locations
More Related Trials
-
Pain Relief After Corneal Collagen Cross-Linking
NCT06212830 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study
NCT04168112 ·Status: COMPLETED ·Phase: PHASE4
-
Fluorometholone Study
NCT07308938 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty
NCT00485108 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)
NCT01023724 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the TetraLens, a Tetracaine Releasing Therapeutic Bandage Contact Lens in Patients Undergoing PRK Procedure
NCT06085352 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Penetrance of Third Generation Fluoroquinolones in Eyes With Functioning Filtering Blebs
NCT00392275 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
NCT06164743 ·Status: COMPLETED ·Phase: PHASE2
-
Levofloxacin Ocular Implant for Ocular Surgery
NCT04682288 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Prostaglandins in the Progression of Diabetic Retinopathy
NCT01609881 ·Status: WITHDRAWN ·Phase: PHASE1
-
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
NCT02951351 ·Status: COMPLETED ·Phase: NA
-
NGF Treatment for Patients With Neuropathic Corneal Pain
NCT05700864 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
NCT04342988 ·Status: COMPLETED ·Phase: PHASE4
-
Pain Management in Corneal Collagen Crosslinking for Keratoconus
NCT02867176 ·Status: COMPLETED ·Phase: PHASE4
-
The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain
NCT06637527 ·Status: TERMINATED ·Phase: PHASE2
-
The Impact of Topical Prostaglandins on the Biomechanical Properties of the Cornea in Patients With Open Angle Glaucoma
NCT02388360 ·Status: COMPLETED ·Phase: PHASE4
-
The Use of MMC During PRK and Its Effect on Postoperative Topical Steroid Requirements
NCT02030990 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Decorin in Sub Scleral Trabeculectomy
NCT03924544 ·Status: UNKNOWN ·Phase: PHASE1
-
Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty
NCT01853696 ·Status: COMPLETED ·Phase: PHASE4
-
A Double-masked, Randomized, Placebo-controlled,Pilot Study of Diquafosol Tetrasodium in Subjects Following Photorefractive Keratectomy (PRK)
NCT01381731 ·Status: TERMINATED ·Phase: PHASE2
-
Steroids and Cross-linking for Ulcer Treatment
NCT04097730 ·Status: COMPLETED ·Phase: PHASE3
-
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)
NCT04246801 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief
NCT00330798 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care
NCT00698724 ·Status: COMPLETED ·Phase: PHASE4
-
RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD
NCT02128113 ·Status: COMPLETED ·Phase: PHASE2